We speculate that the more aggressive course of renal failure in patients with SMARCAL1-associated disease relative to podocin deficiency—which exclusively affects the podocyte—may be related to additional functional effects of defective SMARCAL1 expressed in other nephron structures. This evidence concerns the gene SMARCAL1 and kidney failure.